Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Intraoperative Imaging Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Technological Advancements in Intraoperative Imaging Modalities
3.2.1.2. Increase in R&D activities in medical devices
3.2.1.3. Increasing number of surgical procedures
3.2.2. Restraints
3.2.2.1. High Cost of Intraoperative imaging systems
3.2.2.2. Limited availability of skilled professionals
3.2.3. Opportunity
3.2.3.1. High Growth Opportunities in Emerging Countries
3.2.3.2. Development of low-cost imaging systems
3.2.4. Challenges
3.2.4.1. Higher Budgets of High School
3.2.4.2. Competition from alternative imaging technologies
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Intraoperative Imaging Market Overview
4.1. Market Size & Forecast by Value, 2019-2029
4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Mobile C Arm
4.2.1.2. Ultrasound
4.2.1.2.1. Laparoscopic probes
4.2.1.2.2. Drop-in-probes
4.2.1.2.3. Other devices
4.2.1.3. CT
4.2.1.4. MRI
4.2.1.5. X rays
4.2.1.6. Intraoperative Optical Imaging
4.2.2. By Application
4.2.2.1. Neurosurgery
4.2.2.2. Orthopaedic & Trauma Surgery
4.2.2.3. Spine Surgery
4.2.2.4. Cardiovascular Surgery
4.2.2.5. ENT Surgery
4.2.2.6. Oncology
4.2.2.7. Emergency & Trauma Surgery
4.2.2.8. Others
4.2.3. By Region
4.2.3.1. North America
4.2.3.2. Europe
4.2.3.3. Asia Pacific
4.2.3.4. Latin America
4.2.3.5. Middle East and Africa
5. North America Intraoperative Imaging Market
5.1. Market Size & Forecast by Value, 2019-2029
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Application
5.2.3. By Country
5.2.3.1. United States
5.2.3.1.1. By Product
5.2.3.1.2. By Application
5.2.3.2. Canada
5.2.3.2.1. By Product
5.2.3.2.2. By Application
6. Europe Intraoperative Imaging Market
6.1. Market Size & Forecast by Value, 2019-2029
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Country
6.2.3.1. Germany
6.2.3.1.1. By Product
6.2.3.1.2. By Application
6.2.3.2. United Kingdom
6.2.3.2.1. By Product
6.2.3.2.2. By Application
6.2.3.3. Italy
6.2.3.3.1. By Product
6.2.3.3.2. By Application
6.2.3.4. France
6.2.3.4.1. By Product
6.2.3.4.2. By Application
6.2.3.5. Spain
6.2.3.5.1. By Product
6.2.3.5.2. By Application
6.2.3.6. Belgium
6.2.3.6.1. By Product
6.2.3.6.2. By Application
6.2.3.7. Russia
6.2.3.7.1. By Product
6.2.3.7.2. By Application
6.2.3.8. The Netherlands
6.2.3.8.1. By Product
6.2.3.8.2. By Application
6.2.3.9. Rest of Europe
6.2.3.9.1. By Product
6.2.3.9.2. By Application
7. Asia-Pacific Intraoperative Imaging Market
7.1. Market Size & Forecast by Value, 2019-2029
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Country
7.2.3.1. China
7.2.3.1.1. By Product
7.2.3.1.2. By Application
7.2.3.2. India
7.2.3.2.1. By Product
7.2.3.2.2. By Application
7.2.3.3. Japan
7.2.3.3.1. By Product
7.2.3.3.2. By Application
7.2.3.4. South Korea
7.2.3.4.1. By Product
7.2.3.4.2. By Application
7.2.3.5. Australia & New Zealand
7.2.3.5.1. By Product
7.2.3.5.2. By Application
7.2.3.6. Indonesia
7.2.3.6.1. By Product
7.2.3.6.2. By Application
7.2.3.7. Malaysia
7.2.3.7.1. By Product
7.2.3.7.2. By Application
7.2.3.8. Singapore
7.2.3.8.1. By Product
7.2.3.8.2. By Application
7.2.3.9. Vietnam
7.2.3.9.1. By Product
7.2.3.9.2. By Application
7.2.3.10. Rest of APAC
7.2.3.10.1. By Product
7.2.3.10.2. By Application
8. Latin America Intraoperative Imaging Market
8.1. Market Size & Forecast by Value, 2019-2029
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Country
8.2.3.1. Brazil
8.2.3.1.1. By Product
8.2.3.1.2. By Application
8.2.3.2. Argentina
8.2.3.2.1. By Product
8.2.3.2.2. By Application
8.2.3.3. Peru
8.2.3.3.1. By Product
8.2.3.3.2. By Application
8.2.3.4. Rest of LATAM
8.2.3.4.1. By Product
8.2.3.4.2. By Application
9. Middle East & Africa Intraoperative Imaging Market
9.1. Market Size & Forecast by Value, 2019-2029
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Country
9.2.3.1. Saudi Arabia
9.2.3.1.1. By Product
9.2.3.1.2. By Application
9.2.3.2. UAE
9.2.3.2.1. By Product
9.2.3.2.2. By Application
9.2.3.3. Qatar
9.2.3.3.1. By Product
9.2.3.3.2. By Application
9.2.3.4. Kuwait
9.2.3.4.1. By Product
9.2.3.4.2. By Application
9.2.3.5. South Africa
9.2.3.5.1. By Product
9.2.3.5.2. By Application
9.2.3.6. Nigeria
9.2.3.6.1. By Product
9.2.3.6.2. By Application
9.2.3.7. Algeria
9.2.3.7.1. By Product
9.2.3.7.2. By Application
9.2.3.8. Rest of MEA
9.2.3.8.1. By Product
9.2.3.8.2. By Application
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Intraoperative Imaging Company Market Share Analysis, 2021
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Intraoperative Imaging Market
12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
12.1. General Electric Company
12.2. Siemens Healthineers AG
12.3. Ziehm Imaging GmbH
12.4. Medtronic
12.5. Koninklijke Philips NV
12.6. Canon Healthcare
12.7. Stryker
12.8. Brainlab AG
12.9. IMRIS
12.10. Shimadzu Corporation
12.11. Shenzhen Anke High-tech Co.
12.12. FUJIFILM Holdings
12.13. Carl Zeiss Meditec AG
12.14. Mindray Ltd
12.15. Carestream Health
12.16. Analogic Corporation
12.17. Allengers Medical Systems Ltd
12.18. Esaote SpA
12.19. Neurologica Corporation
12.20. Other Prominent Companies
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumption & Limitation
*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable